Journal article icon

Journal article

Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis

Abstract:
Background A 14-day course of primaquine is used for radical cure of Plasmodium vivax and Plasmodium ovale malaria only. We quantified the risk of P vivax parasitaemia after treatment of Plasmodium falciparum with commonly used antimalarial drugs to assess the potential benefits of radical cure for all patients with uncomplicated malaria in co-endemic regions. Methods In this systematic review and meta-analysis, we searched MEDLINE, Embase, Web of Science, a... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1016/s1473-3099(18)30596-6

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM
Subgroup:
Tropical Medicine
Simpson, JA More by this author
Thriemer, K More by this author
Hossain, MS More by this author
Douglas, NM More by this author
Expand authors...
More from this funder
Funding agency for:
Price, RN
More from this funder
Grant:
Australian Centre for Research Excellence on Malaria Elimination (ACREME) APP 1134989
Publisher:
Elsevier Publisher's website
Journal:
Lancet Infectious Diseases Journal website
Volume:
19
Issue:
1
Pages:
91-101
Publication date:
2018-12-19
Acceptance date:
2018-09-13
DOI:
ISSN:
1473-3099
Pubs id:
pubs:953475
URN:
uri:94856235-d8f7-4327-8aad-99993603dd3a
UUID:
uuid:94856235-d8f7-4327-8aad-99993603dd3a
Local pid:
pubs:953475
Language:
English

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP